HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dorianna Sandonà Selected Research

Sarcoglycans (beta Sarcoglycan)

1/2022CFTR corrector C17 is effective in muscular dystrophy, in vivo proof of concept in LGMDR3.
3/2020Combined Use of CFTR Correctors in LGMD2D Myotubes Improves Sarcoglycan Complex Recovery.
1/2018Repairing folding-defective α-sarcoglycan mutants by CFTR correctors, a potential therapy for limb-girdle muscular dystrophy 2D.
7/2014Unveiling the degradative route of the V247M α-sarcoglycan mutant responsible for LGMD-2D.
9/2009Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects.
7/2008Inhibition of proteasome activity promotes the correct localization of disease-causing alpha-sarcoglycan mutants in HEK-293 cells constitutively expressing beta-, gamma-, and delta-sarcoglycan.
11/2005Deficiency of alpha-sarcoglycan differently affects fast- and slow-twitch skeletal muscles.
7/2004Characterization of the ATP-hydrolysing activity of alpha-sarcoglycan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dorianna Sandonà Research Topics

Disease

5Sarcoglycanopathies
03/2020 - 07/2008
4Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
01/2022 - 11/2005
3Atrophy
01/2012 - 01/2008
2Muscular Dystrophies (Muscular Dystrophy)
01/2022 - 07/2004
2Cystic Fibrosis (Mucoviscidosis)
01/2022 - 03/2020
2Inborn Genetic Diseases (Disease, Hereditary)
07/2014 - 09/2009
1Ovarian Neoplasms (Ovarian Cancer)
01/2022
1Ovarian Epithelial Carcinoma
01/2022
1Neoplasms (Cancer)
01/2022
1Isaacs Syndrome (Neuromyotonia)
11/2014
1Muscular Atrophy (Muscle Atrophy)
01/2008
1Fatigue
03/2006

Drug/Important Bio-Agent (IBA)

8Sarcoglycans (beta Sarcoglycan)IBA
01/2022 - 07/2004
6Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2008
2UbiquitinIBA
11/2014 - 01/2012
2Ligases (Synthetase)IBA
07/2014 - 01/2012
1Estrogens (Estrogen)FDA Link
01/2022
1MicroRNAs (MicroRNA)IBA
01/2022
1Proteasome Endopeptidase Complex (Proteasome)IBA
11/2014
1Adenosine Triphosphatases (ATPase)IBA
11/2014
1Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
07/2014
1Pharmaceutical PreparationsIBA
07/2014
1EnzymesIBA
07/2014
1LipidsIBA
03/2010
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
03/2010
1Glycoproteins (Glycoprotein)IBA
09/2009
1SphingosineIBA
01/2008
1Protein Isoforms (Isoforms)IBA
03/2006
1Homer Scaffolding Proteins (Homer 1)IBA
03/2006

Therapy/Procedure

4Therapeutics
03/2020 - 07/2008
2Denervation
03/2010 - 01/2008